| ID | Sequence | Length | GC content |
|---|---|---|---|
| lnc-MSX1-2:1 | AAAUUUUGCAUUCGGCUGCCUUAGCACUCUGCGUCCUCGCACCGACCCU… | 2341 nt | 0.4652 |
| lnc-MSX1-2:2 | AAUUGCAGACUGGCCUUUACAAGGGAAAAACCCAGGCCCUGCCCUAAAU… | 2386 nt | 0.4665 |
| lnc-MSX1-2:3 | GCAUUCGGCUGCCUUAGCACUCUGCGUCCUCGCACCGACCCUGGGGUCC… | 435 nt | 0.5356 |
| lnc-MSX1-2:4 | GCAUUCGGCUGCCUUAGCACUCUGCGUCCUCGCACCGACCCUGGGGUCC… | 475 nt | 0.5032 |
| lnc-MSX1-2:5 | GCAUUCGGCUGCCUUAGCACUCUGCGUCCUCGCACCGACCCUGGGGUCC… | 18797 nt | 0.4666 |
No relevant information is available at the moment.
A study in human postmortem midbrain specimens demonstrated that the lnc-MSX1-2 was significantly down-regulated (-1.35-fold) in chronic cocaine abusers compared to well-matched controls, as identified via a custom lncRNA microarray [Bannon et al. DOI:10.1111/jnc.13255]. This antisense lncRNA was part of a validated profile of 32 dysregulated lncRNAs, implicating it in the cellular responses of human dopamine neurons to chronic cocaine abuse.